N06.6
Isolated proteinuria with dense deposit disease
Clinical Classification Guidelines
Inclusion Terms
- Isolated proteinuria with C3 glomerulopathy with dense deposit disease
- Isolated proteinuria with membranoproliferative glomerulonephritis, type 2
Medical Intelligence & Overview
Isolated proteinuria with dense deposit disease (ICD-10 code N06.6) is a kidney condition characterized by the presence of excess protein in the urine, linked to a specific form of glomerulopathy known as dense deposit disease. This condition involves abnormal immune complex deposits in the kidneys, which can impact kidney function over time. Recognizing and understanding this disorder is crucial for appropriate management and monitoring.
Causes & Symptoms
Clinical Causes: Complement system dysregulation, especially involving C3 components Genetic mutations affecting immune regulation and complement pathways Underlying immune complex diseases that trigger glomerular damage Presence of dense deposit disease or C3 glomerulopathy Other factors leading to immune activation within the kidneys
Key Symptoms: Persistent proteinuria, often detected through urine tests Hematuria (blood in urine) in some cases Swelling or edema, particularly in the legs and around the eyes High blood pressure (hypertension) Reduced kidney function over time, which may develop gradually Possible signs of nephrotic syndrome in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of laboratory tests and kidney biopsy. The key steps include: - Urinalysis to detect protein and blood in urine - Blood tests to assess kidney function and complement levels - Kidney biopsy to identify dense deposit disease characterized by dense, ribbon-like deposits in the glomerular basement membrane under microscopy - Electron microscopy to visualize the dense deposits within the glomeruli - Complement testing to evaluate abnormalities in the immune system’s complement pathway The integration of these findings helps confirm the presence of dense deposit disease associated with proteinuria.
Treatment Protocols: While specific treatments may vary depending on the case, management strategies typically include: - Blood pressure control using antihypertensive medications - Use of drugs that suppress immune activity, such as corticosteroids or immunosuppressants, in selected cases - Measures to reduce proteinuria, which may include angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) - Monitoring kidney function regularly to detect any decline early - In some cases, plasma exchange or complement inhibitors might be considered, especially when immune dysregulation is prominent - Dietary adjustments to support kidney health, - Avoidance of nephrotoxic medications and substances The focus is on slowing disease progression and managing symptoms, as there is no cure for dense deposit disease itself.
Clinical Advice & FAQs
Billing Guidance
Is N06.6 a billable ICD-10 code?
Yes, N06.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N06.6?
Clinical documentation must specify the nature of Isolated proteinuria with dense deposit disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference